Jin Yang Pharmaceutical Co. Ltd (007370) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.64 Billion ≈ $1.11 Million USD) by net assets (₩127.68 Billion ≈ $86.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jin Yang Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 007370 current and long-term liabilities for a breakdown of total debt and financial obligations.

Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Vate Technology Co Ltd TWO:5344	-0.022x
Mondi PLC LSE:MNDI	0.036x
Neptis WAR:YAN	0.243x
Woosung Feed KO:006980	0.128x
Talphera Inc. NASDAQ:TLPH	-0.131x
Ferroamp Elektronik AB ST:FERRO	-0.003x
Legacy Iron Ore Ltd AU:LCY	0.043x
Globalink Investment Inc NASDAQ:GLLI	-0.010x

Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Jin Yang Pharmaceutical Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩119.88 Billion ≈ $81.24 Million	₩12.79 Billion ≈ $8.67 Million	0.107x	+12.02%
2023-12-31	₩89.58 Billion ≈ $60.71 Million	₩8.53 Billion ≈ $5.78 Million	0.095x	-0.78%
2022-12-31	₩77.58 Billion ≈ $52.57 Million	₩7.45 Billion ≈ $5.05 Million	0.096x	+218.24%
2021-12-31	₩65.32 Billion ≈ $44.26 Million	₩1.97 Billion ≈ $1.34 Million	0.030x	-77.63%
2020-12-31	₩46.31 Billion ≈ $31.38 Million	₩6.24 Billion ≈ $4.23 Million	0.135x	-18.33%
2019-12-31	₩43.67 Billion ≈ $29.59 Million	₩7.21 Billion ≈ $4.89 Million	0.165x	+555.78%
2018-12-31	₩42.05 Billion ≈ $28.50 Million	₩1.06 Billion ≈ $717.38K	0.025x	+208.08%
2017-12-31	₩42.38 Billion ≈ $28.72 Million	₩-987.16 Million ≈ $-668.99K	-0.023x	-8399.26%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-13.47 Million ≈ $-9.13K	0.000x	+99.41%
2015-12-31	₩59.18 Billion ≈ $40.10 Million	₩-2.76 Billion ≈ $-1.87 Million	-0.047x	+7.06%
2014-12-31	₩61.48 Billion ≈ $41.66 Million	₩-3.08 Billion ≈ $-2.09 Million	-0.050x	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$41.53 Million

₩61.28 Billion KRW

Market Cap Rank

#22563 Global

#1532 in Korea

Share Price

₩4960.00

Change (1 day)

+0.20%

52-Week Range

₩4370.00 - ₩6740.00

All Time High

₩9262.22